Sonal Singh to United States Food and Drug Administration
This is a "connection" page, showing publications Sonal Singh has written about United States Food and Drug Administration.
Connection Strength
1.101
-
Pradhan R, Singh S. Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis. Drug Saf. 2018 Sep; 41(9):849-857.
Score: 0.591
-
Singh S. The Safety of Generic Prescription Drugs in the United States. Drug Saf. 2018 Apr; 41(4):325-328.
Score: 0.143
-
Iyer G, Marimuthu SP, Segal JB, Singh S. An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System. Drug Saf. 2017 09; 40(9):799-808.
Score: 0.138
-
Marimuthu SP, Iyer G, Segal JB, Singh S. Patient-relevant outcomes associated with generic tamsulosin, levothyroxine and amphetamine in the FDA Adverse Event Reporting System: a pilot study. J Comp Eff Res. 2017 Jul; 6(5):437-447.
Score: 0.136
-
Moore TJ, Singh S, Furberg CD. The FDA and new safety warnings. Arch Intern Med. 2012 Jan 09; 172(1):78-80.
Score: 0.093